Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Sanofi has agreed to buy Protein Sciences, a vaccines manufacturer, for $650 million. Based in Connecticut, Protein Sciences received FDA approval in October for Flublok Quadrivalent, which it touts as the only recombinant protein-based influenza vaccine to be cleared by the agency. “The acquisition of Protein Sciences will allow us to broaden our flu portfolio with the addition of a non-egg-based vaccine,” says David Loew, head of Sanofi’s vaccines division. Sanofi will pay as much as $100 million more if certain milestones are hit.
This article has been sent to the following recipient: